Inherent Biosciences

Developer of epigenetic diagnostics and therapeutics for complex diseases

placeSalt Lake City, Utah, United States calendar_todayFounded 2019 groups15 employees language inherentbio.com

Innovation

2 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace accelerating. Cited 195 times.

YearFilings
20221
20231
20242
20252
20261

Investor mix

14 investors on record; lead investors include Propel Bio Partners.

Investor typeCountShare
Venture capital536%
Angel & family office214%
Other / undisclosed750%
Coming soon